At first glance, the Dow Jones Industrial Average's
The weakest performers were economically sensitive stocks. Alcoa
In contrast, news pushed some stocks up. Verizon
Meanwhile, Merck climbed more than 1% despite saying that the FDA failed to approve its combination cholesterol drug. Promising phase 3 data from another drug apparently outweighed the bad news.
What will tomorrow bring?
Daily moves in the Dow may be interesting, but it's the long haul you should really focus on. Start thinking about market-crushing returns by taking a look at the one stock that the Fool's chief investment officer picked it to crush the market. You'll find out its name in this free report: "The Motley Fool's Top Stock for 2012." Instant access is just a click away.
Fool contributor Dan Caplinger doesn't own shares of the companies mentioned. You can follow him on Twitter. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.